Related references
Note: Only part of the references are listed.The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber et al.
BLOOD (2016)
JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes
Elisa Rumi et al.
BLOOD (2014)
The role of serum erythropoietin level and jak2 v617f allele burden in the diagnosis of polycythaemia vera
Agueda Ancochea et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
A prognostic model to predict survival in 867 World Health Organization-defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment
Francesco Passamonti et al.
BLOOD (2012)
Erythropoietin concentration in the serum from patients with primary thrombocythaemia
Y. Najean et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Plasma erythropoietin by high-detectability immunoradiometric assay in untreated and treated patients with polycythaemia vera and essential thrombocythaemia
Jan Carneskog et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Hydroxyurea therapy increases plasma erythropoietin in patients with essential thrombocythaemia or polycythaemia vera
P. Johansson et al.
CLINICAL AND LABORATORY HAEMATOLOGY (2006)
Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status:: a prospective study
PJ Campbell et al.
LANCET (2005)
The relation between plasma thrombopoietin and erythropoietin concentrations in polycythaemia vera and essential thrombocythaemia
B Andréasson et al.
LEUKEMIA & LYMPHOMA (2001)
Plasma erythropoietin in essential thrombocythaemia:: at diagnosis and in response to myelosuppressive treatment
B Andréasson et al.
LEUKEMIA & LYMPHOMA (2000)
Share Paper
